Proposed Research Protocol For Male Infertility
Primary Purpose
Male Infertility
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Male Infertility Protocol
Sponsored by
About this trial
This is an interventional treatment trial for Male Infertility focused on measuring male infertility, natural cycle IVF, in-vitro fertilization, intrauterine inseminatio
Eligibility Criteria
Inclusion Criteria:
- Couples with "pure" male factor infertility of six months or more, defined as not pregnant in spite of being desirous of pregnancy for at least six months with normal sexual activity and no birth control. Primary and Secondary infertility included.
- Abnormality of any one of the sperm parameters according to WHO or Kruger for concentration, motility or morphology.
- Women aged 18 to 30 with a BMI between 18 and 30
- Women who testify that they are healthy with regular menstrual cycles between 25-35 days per cycle.
Exclusion Criteria:
- Uterine fibroids or ovarian cysts or tumors or suspected hydrosalpinx on US on prior fertility workup. Paraovarian simple cysts, OK.
- Prior PID, abdominal or pelvic surgery or abnormal HSG if done.
- Known allergy to medications used in protocol
- Diagnosed or suspected genetic or psychiatric disease in either patient.
- Azoospermia
- Female partner with a history of infertility with another partner
- Elevated FSH (over 10 units/L) in female partner if done.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Male Infertility Protocol
Arm Description
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT01255397
First Posted
December 6, 2010
Last Updated
December 6, 2010
Sponsor
HaEmek Medical Center, Israel
1. Study Identification
Unique Protocol Identification Number
NCT01255397
Brief Title
Proposed Research Protocol For Male Infertility
Official Title
Proposed Research Protocol For Male Infertility
Study Type
Interventional
2. Study Status
Record Verification Date
December 2010
Overall Recruitment Status
Unknown status
Study Start Date
January 2011 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
HaEmek Medical Center, Israel
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this experiment is to test the feasibility of a minimally interventionist protocol for young couples with male factor infertility, which addresses the cause of infertility for these couples which is the inability of the sperm to fertilize the egg.Ultrasound monitoring of natural follicular development utilizing rFSH, GnRH antagonist and rHCG only for the final maturation. Single follicle aspiration and IUI or IVF/ICSI based on sperm charcteristics on the day of fertilization. Fertilized eggs transfered to the uterus on the same day as the aspiration.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Male Infertility
Keywords
male infertility, natural cycle IVF, in-vitro fertilization, intrauterine inseminatio
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Male Infertility Protocol
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Male Infertility Protocol
Intervention Description
Healthy women with a regular cycle between 28 and 35 days. For the man, an abnormal sperm exam.
Daily US examinations from day 8 of the menstrual cycle. Excluding weekends.
When the leading follicle is 14 mm she will be given 100 units puregon and orgalutran,once daily until the leading follicle is at least 16 mm at which point she will be given ovitrelle at 21:00.
35 hours after Ovitrelle at 8:00 the husband will present a sperm sample for analysis. A pelvic US will be done to the wife.
If the follicle has collapsed than IUI will be performed
It the total motile sperm count is above 5 million sperm/ml then IUI will be done
If the total motile sperm count is below 5 million and the follicle has not collapsed, proceed to oocyte aspiration and ICSI
6) ICSI and embryo transfer performed on the same day. 7) Luteal support: Endometrin 100 mg twice a day following IUI\ET until 6 weeks gestation Protocol can be repeated for up to 3 cycles per couple.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Couples with "pure" male factor infertility of six months or more, defined as not pregnant in spite of being desirous of pregnancy for at least six months with normal sexual activity and no birth control. Primary and Secondary infertility included.
Abnormality of any one of the sperm parameters according to WHO or Kruger for concentration, motility or morphology.
Women aged 18 to 30 with a BMI between 18 and 30
Women who testify that they are healthy with regular menstrual cycles between 25-35 days per cycle.
Exclusion Criteria:
Uterine fibroids or ovarian cysts or tumors or suspected hydrosalpinx on US on prior fertility workup. Paraovarian simple cysts, OK.
Prior PID, abdominal or pelvic surgery or abnormal HSG if done.
Known allergy to medications used in protocol
Diagnosed or suspected genetic or psychiatric disease in either patient.
Azoospermia
Female partner with a history of infertility with another partner
Elevated FSH (over 10 units/L) in female partner if done.
12. IPD Sharing Statement
Learn more about this trial
Proposed Research Protocol For Male Infertility
We'll reach out to this number within 24 hrs